Jim Cramer Prefers Intuitive Surgical, Inc. (NASDAQ:ISRG) Over Procept Biorobotics
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $550
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
Stocks That Are Set to Benefit From Either Harris or Trump Winning Scenarios – Barclays
Intuitive Surgical, Inc. (ISRG): Hedge Funds Are Bullish On This Trending AI Stock Right Now